Sinopharm Group Co
- SectorPharmaceuticals & Biotechnology
SINOPHARM GROUP CO.LTD. (HK), a company active in the Drug Retailers industry, loses a star(s) at the fundamental level and sees its general evaluation downgraded. The independent financial analyst theScreener just removed a fundamental star(s) for a 3 over 4-star rating. As such, market behaviour remains unchanged and is evaluated as moderately risky. theScreener believes that the loss of a star(s) merits downgrade to the general evaluation of the title, which passes to Neutral. As of the analysis date January 21, 2020, the closing price was HKD 27.55 and its expected value was estimated at H...
Feasibility Study Results in December to be a Catalyst for this Junior